Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PKD1P2 is a human pseudogene that resembles the functional PKD1 gene, which encodes polycystin 1—a protein involved in the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD)[1][4][8][10]. PKD1P2 does not encode a functional protein; instead, it is one of several pseudogenes that arose from gene duplication events and retains substantial sequence similarity to PKD1. Although PKD1P2 itself has no known biological activity or disease association, its presence can complicate genetic diagnosis of ADPKD because standard sequencing approaches may inadvertently amplify or detect variants from PKD1P2 rather than PKD1, potentially leading to misdiagnosis[10]. Thus, PKD1P2 is relevant primarily in the context of genetic testing, but not as a receptor, enzyme, or other therapeutic target[3][9][10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polycystin 1, transient receptor potential channel interacting pseudogene 2 (PKD1P2).